Guidelines and Recommendations for the Management of Anaemia in Patients with Lymphoid Malignancies

By Henry David H.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 175-194

Adis International

Access to resources Recommend Favorite

Milatuzumab: a promising new agent for the treatment of lymphoid malignancies

By Mark Tomer   Martin Peter   Leonard John P   Niesvizky Ruben  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Cell Death Targeting Therapies in B Lymphoid Malignancies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 769-780

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

By Korycka-Wołowiec Anna   Robak Tadeusz  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1455-1468

Informa Healthcare

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite